denufosol tetrasodium
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Merck Sharp & Dohme LLC
Overview
denufosol tetrasodium is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
denufosol tetrasodium clinical trials
Explore related
Medical disclaimer. This page summarizes research about denufosol tetrasodium for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.